Views & Analysis Digital health round-up: Hacking medical devices, robot phar... Richard Staines presents a round-up of the week's digital health news
Views & Analysis How AI and blockchain can reduce corruption in Big Pharma Gunjan Bhardwaj gives his opinion how new technologies can help reduce corruption in the pharma industry.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.